Company Filing History:
Years Active: 1976-1977
Title: The Innovations of Bunzo Nomiya
Introduction
Bunzo Nomiya is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel antibiotic compositions. With a total of two patents to his name, Nomiya's work showcases his dedication to improving therapeutic options.
Latest Patents
Nomiya's latest patents include the "Antibiotic 9-acyl-3'-thiomethoxymethyl-SF-837 composition and process." This innovative derivative of the macrolide antibiotic SF-837 is produced by treating a 9,2'-diacyl- or 9-acyl-SF-837 composition with dimethylsulfoxide and acetic anhydride, followed by treatment with an alcohol or water-containing solvent. This novel compound not only exhibits high therapeutic effectiveness and low acute toxicity but also eliminates the bitter taste associated with its parent compounds, making it suitable for pediatric and veterinary use. Another significant patent is the "Composition for treating swine scour," which introduces novel alkyl 2,3,3-triiodoallyl ethers as disinfectants. These compounds are created through an addition reaction of alkyl-3-iodo-2-propinyl ethers with iodine, providing effective solutions for both poultry feed additives and swine scour treatment.
Career Highlights
Throughout his career, Bunzo Nomiya has worked with prominent companies such as Meiji Seika Co., Ltd. and Meiji Seika Kaisha, Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Nomiya has collaborated with esteemed colleagues, including Shigeharu Inouye and Shoji Omoto. These partnerships have fostered an environment of innovation and creativity, leading to the development of impactful inventions.
Conclusion
Bunzo Nomiya's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to advancing medical science. His work not only addresses critical health issues but also enhances the quality of life for patients.